GB2246514B - Sustained release pharmaceutical compositions and the preparation of particles for use therein - Google Patents

Sustained release pharmaceutical compositions and the preparation of particles for use therein

Info

Publication number
GB2246514B
GB2246514B GB9116472A GB9116472A GB2246514B GB 2246514 B GB2246514 B GB 2246514B GB 9116472 A GB9116472 A GB 9116472A GB 9116472 A GB9116472 A GB 9116472A GB 2246514 B GB2246514 B GB 2246514B
Authority
GB
United Kingdom
Prior art keywords
particles
preparation
pharmaceutical compositions
sustained release
release pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9116472A
Other versions
GB2246514A (en
GB9116472D0 (en
Inventor
Jean-Marc Ruiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016885A external-priority patent/GB9016885D0/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to GB9116472A priority Critical patent/GB2246514B/en
Publication of GB9116472D0 publication Critical patent/GB9116472D0/en
Publication of GB2246514A publication Critical patent/GB2246514A/en
Application granted granted Critical
Publication of GB2246514B publication Critical patent/GB2246514B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9116472A 1990-08-01 1991-07-31 Sustained release pharmaceutical compositions and the preparation of particles for use therein Expired - Fee Related GB2246514B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9116472A GB2246514B (en) 1990-08-01 1991-07-31 Sustained release pharmaceutical compositions and the preparation of particles for use therein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions
GB9116472A GB2246514B (en) 1990-08-01 1991-07-31 Sustained release pharmaceutical compositions and the preparation of particles for use therein

Publications (3)

Publication Number Publication Date
GB9116472D0 GB9116472D0 (en) 1991-09-11
GB2246514A GB2246514A (en) 1992-02-05
GB2246514B true GB2246514B (en) 1993-12-15

Family

ID=26297422

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9116472A Expired - Fee Related GB2246514B (en) 1990-08-01 1991-07-31 Sustained release pharmaceutical compositions and the preparation of particles for use therein

Country Status (1)

Country Link
GB (1) GB2246514B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5849240A (en) 1993-11-23 1998-12-15 Euro-Celtique, S.A. Method of preparing sustained release pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5958452A (en) 1994-11-04 1999-09-28 Euro-Celtique, S.A. Extruded orally administrable opioid formulations
US6068855A (en) 1994-11-03 2000-05-30 Euro-Celtique S. A. Pharmaceutical composition containing a fusible carrier and method for producing the same
US6254887B1 (en) 1993-05-10 2001-07-03 Euro-Celtique S.A. Controlled release tramadol
US6528093B1 (en) 1992-12-07 2003-03-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
US8920842B2 (en) 1999-11-15 2014-12-30 Piramal Healthcare (Canada) Ltd. Temperature controlled and pH dependent self gelling biopolymeric aqueous solution

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639048A1 (en) * 1992-05-05 1995-02-22 E.I. Du Pont De Nemours And Company Microencapsulation
JP3277342B2 (en) * 1992-09-02 2002-04-22 武田薬品工業株式会社 Manufacturing method of sustained release microcapsules
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
ATE228832T1 (en) * 1994-02-28 2002-12-15 Nanopharm Ag SYSTEM FOR THE TARGETED DELIVERY OF ACTIVE INGREDIENTS, METHOD FOR THE PRODUCTION AND USE THEREOF
DE19500977C2 (en) * 1995-01-14 1999-01-07 Lohmann Therapie Syst Lts Solid drug form with active ingredient distributed in polymeric material
TW448055B (en) * 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
FR2748205A1 (en) 1996-05-06 1997-11-07 Debio Rech Pharma Sa PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF INSOLUBLE ACTIVE SUBSTANCES
US6419961B1 (en) 1996-08-29 2002-07-16 Takeda Chemical Industries, Ltd. Sustained release microcapsules of a bioactive substance and a biodegradable polymer
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
FR2776516B1 (en) * 1998-03-25 2001-05-25 Pharma Biotech COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD
FR2762318B1 (en) * 1997-04-18 1999-09-17 Pharma Biotech COMPOSITIONS HAVING SUSTAINED RELEASE AND A PROCESS FOR THEIR PREPARATION
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
KR100289471B1 (en) * 1998-01-19 2001-09-17 김충섭 A controlled/sustained implant delivery containing fentanyls
KR19990065921A (en) * 1998-01-19 1999-08-16 김충섭 Antimicrobial sustained-release drugs
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
FR2865938B1 (en) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic SOLID DELAY FORMULATION COMPRISING TRIPTORELINE ACETATE

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528093B1 (en) 1992-12-07 2003-03-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6326027B1 (en) 1993-05-10 2001-12-04 Euro-Celtique S.A. Controlled release formulation
US6254887B1 (en) 1993-05-10 2001-07-03 Euro-Celtique S.A. Controlled release tramadol
US5849240A (en) 1993-11-23 1998-12-15 Euro-Celtique, S.A. Method of preparing sustained release pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5965163A (en) 1993-11-23 1999-10-12 Euro-Celtique, S.A. Substained release compositions and a method of preparing pharmaceutical compositions
US6162467A (en) 1993-11-23 2000-12-19 Euro-Celtique, S.A. Sustained release compositions and a method of preparing pharmaceutical compositions
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US6068855A (en) 1994-11-03 2000-05-30 Euro-Celtique S. A. Pharmaceutical composition containing a fusible carrier and method for producing the same
US5958452A (en) 1994-11-04 1999-09-28 Euro-Celtique, S.A. Extruded orally administrable opioid formulations
US6261599B1 (en) 1994-11-04 2001-07-17 Euro-Celtique, S.A. Melt-extruded orally administrable opioid formulations
US6335033B2 (en) 1994-11-04 2002-01-01 Euro-Celtique, S.A. Melt-extrusion multiparticulates
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6706281B2 (en) 1994-11-04 2004-03-16 Euro-Celtique, S.A. Melt-extrusion multiparticulates
US8920842B2 (en) 1999-11-15 2014-12-30 Piramal Healthcare (Canada) Ltd. Temperature controlled and pH dependent self gelling biopolymeric aqueous solution

Also Published As

Publication number Publication date
GB2246514A (en) 1992-02-05
GB9116472D0 (en) 1991-09-11

Similar Documents

Publication Publication Date Title
HK33294A (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
GB2246514B (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
IL102591A0 (en) Compositions for the sustained and controlled release of medicaments and their preparation
HK1007108A1 (en) Compositions and methods for the controlled release of soluble active substances
NZ238545A (en) Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
GB2230185B (en) Sustained release pharmaceutical compositions
IL107978A0 (en) Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL113123A (en) Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
ZA904925B (en) Sustained release pharmaceutical compositions
IL98477A0 (en) Resorption-improved pharmaceutical somatostatin compositions and their preparation
IL98934A0 (en) Stable pharmaceutical compositions and their preparation
HUT67287A (en) Piperazynil camphor derivatives and pharmaceutical compositions containing them
IL84104A0 (en) Sustained release pharmaceutical compositions and their preparation
ZA933426B (en) New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
IL102116A (en) Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL115981A0 (en) Cyclolignan derivatives procosses for the preparation thereof and pharmaceutical compositions containing the same
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
SG25394G (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein.
IL93139A0 (en) Pharmaceutical compositions comprising suramin and methods for the use thereof
NZ240873A (en) 6-cyclohexyl-2'-o-methyl-adenosine hydrate preparation and pharmaceutical compositions thereof
IL94194A0 (en) Pharmaceutical compositions containing piperidinyl-benzocycloheptathiophenone derivatives and methods for the use thereof
HU9802779D0 (en) Azol-derivatives of cycloalkylenes and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20090731